WO2026032964 - ANTIMICROBIAL PEPTIDOMIMETICS
National phase entry is expected:
Publication Number
WO/2026/032964
Publication Date
12.02.2026
International Application No.
PCT/EP2025/072478
International Filing Date
05.08.2025
Title **
[English]
ANTIMICROBIAL PEPTIDOMIMETICS
[French]
PEPTIDOMIMÉTIQUES À ACTIVITÉ ANTIMICROBIENNE
Applicants **
BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
UNIVERSITÄT ZÜRICH
Inventors
BRABET, Emile
BENGHEZAL, Mohammed
UPERT, Grégory
JUNG, Françoise
D'ARCO, Carolin
STIEGELER, Sarah
Priority Data
24193117.9
06.08.2024
EP
63/679,696
06.08.2024
US
25169131.7
08.04.2025
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2583 | |
| EPO | Filing, Examination, Granting | 12603 | |
| Japan | Filing, Examination, Granting | 2370 | |
| South Korea | Filing, Examination, Granting | 2571 | |
| USA | Filing, Examination, Granting | 6940 |
Total:
27,067
Contact Us
Abstract[English]
(I) and salts thereof, in particular pharmaceutically acceptable salts thereof, as described in the description and in the claims. The invention is also directed to therapeutic uses of the peptidomimetics for the treatment or prevention of bacterial infections and diseases related to bacterial infections and to non-therapeutic uses of the peptidomimetics for preserving or disinfecting foodstuffs, cosmetics, medicaments or other nutrient-containing materials.[French]
(I) et leurs sels, en particulier des sels pharmaceutiquement acceptables de ceux-ci, tels que décrits dans la description et dans les revendications. L'invention concerne également des utilisations thérapeutiques des peptidomimétiques pour le traitement ou la prévention d'infections bactériennes et de maladies associées à des infections bactériennes et des utilisations non thérapeutiques des peptidomimétiques pour la conservation ou la désinfection de produits alimentaires, de produits cosmétiques, de médicaments ou d'autres matériaux contenant des nutriments.